A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03844932 · TERMINATED
Trial details
- NCT number
- NCT03844932
- Sponsor
- Sublimity Therapeutics Holdco Limited
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-24
- Primary completion
- 2021-04-14
- Enrollment
- 235
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.